We are live on ! Find out more
ELOS

Syneron Medical Ltd
ELOS

Delisted

ELOS was delisted on the 14th of July, 2017.

Back to rankings

79 hedge funds and large institutions have $276M invested in Syneron Medical Ltd in 2015 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 25 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

998% more call options, than puts

Call options by funds: $516K | Put options by funds: $47K

8% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 25

8% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 12

1% less funds holding

Funds holding: 80 → 79 (-1)

13% less capital invested

Capital invested by funds: $319M → $276M (-$42.7M)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
79
Holders Change
-1
Holders Change %
-1.25%
% of All Funds
2.13%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
11
Increased
23
Reduced
25
Closed
12
Calls
$516K
Puts
$47K
Net Calls
+$469K
Net Calls Change
+$118K

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$15.8M
2
ECM
Endurant Capital Management
California
+$2.71M
3
DGHMC
Dalton, Greiner, Hartman, Maher & Co
New York
+$2.2M
4
ACM
Argent Capital Management
Missouri
+$1.56M
5
Renaissance Technologies
Renaissance Technologies
New York
+$1.09M

Top Sellers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
-$10.5M
2
BIP
Brandes Investment Partners
California
-$3.46M
3
RA
Royce & Associates
New York
-$1.46M
4
Victory Capital Management
Victory Capital Management
Texas
-$959K
5
Citadel Advisors
Citadel Advisors
Florida
-$958K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
76
Citigroup
New York
$1K +$82 +7 +8%
TRCT
77
Tower Research Capital (TRC)
New York
$1K +$246 +21 +57%
DC
78
Davenport & Co
Virginia
– -$826K -66,700 Closed
CSS
79
Cubist Systematic Strategies
Connecticut
– -$398K -32,126 Closed
DekaBank Deutsche Girozentrale
80
DekaBank Deutsche Girozentrale
Germany
– -$371K -30,000 Closed
EMG
81
Ellington Management Group
Connecticut
– -$358K -28,900 Closed
HHC
82
Hutchin Hill Capital
New York
– -$357K -28,800 Closed
Bank of New York Mellon
83
Bank of New York Mellon
New York
– -$304K -24,563 Closed
Nomura Holdings
84
Nomura Holdings
Japan
– -$294K -24,034 Closed
CS
85
Credit Suisse
Switzerland
– -$271K -21,854 Closed
RC
86
RBF Capital
California
– -$161K -12,997 Closed
PCM
87
Prelude Capital Management
New York
– -$45K -3,616 Closed
Group One Trading
88
Group One Trading
Illinois
– -$28K -2,250 Closed
Creative Planning
89
Creative Planning
Kansas
– -$5K -400 Closed
Barclays
90
Barclays
United Kingdom
– -$12 -1 -8%
Simplex Trading
91
Simplex Trading
Illinois
– +$796 +68 New
1 2 3
4

ELOS Hedge Fund Activity: Q2 2015 in Review

79 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q2 2015, worth a combined $276M — down 13% from $319M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of ELOS and 11 opened new positions — a net loss of 1 holder — while 25 trimmed existing stakes and 23 added.

The largest buyer was Deerfield Management, adding an estimated $15.8M. The largest seller was Visium Asset Management, cutting an estimated $10.5M.

  • 79 institutional investors held Syneron Medical Ltd (ELOS) as of Q2 2015, down from 80 in Q1 2015.
  • Funds reported $276M of Syneron Medical Ltd stock for Q2 2015, down 13% quarter-over-quarter.
  • 11 funds opened new Syneron Medical Ltd positions in Q2 2015 and 12 closed out, a net change of -1 holder.
  • The largest Syneron Medical Ltd buyer in Q2 2015 was Deerfield Management, an estimated $15.8M added.
  • The largest Syneron Medical Ltd seller in Q2 2015 was Visium Asset Management, an estimated $10.5M sold.

Based on aggregated 13F filings for Q2 2015.